A Clinical trial to evaluate the effectiveness of Adathodai Nei (Medicated Ghee) in the management of Swasakaasam (Bronchial Asthma)

An Open Non Randomized Clinical Trial To Evaluate The Therapeutic Effectiveness of Adathodai Nei for The Management of Swasakaasam (Bronchial Asthma) Among Patients Reporting Out Patients Department of Ayothidoss Pandithar Hospital,National Institute of Siddha

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040237

Enrollment

Registered

2022-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Adathodai Nei: 5ml Bd With Hot Water Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical symptoms of Sneezing, Rhinitis, Dyspnea, Cough with or without expectoration, Wheeze, Tightness of chest. 2.Wheezing more than 3 weeks. 3.Night time wheezing more than one day/week. 4.Asthma sometimes interferes with normal daily activities. 5.Patients who are willing to undergo spirometry, radiological investigations and provide blood sample for lab investigations.

Exclusion criteria

Exclusion criteria: KNOWN CASE OF 1.Having covid-19 (or) past history of covid-19 2.Restrictive Lung diseases 3.Tuberculosis 4.Emphysema 5.Pleural effusion 6.Pneumothorax 7.Cardiac diseases and Renal diseases 8.Sleep Apnea 9.Diabetes mellitus 10.Hypertension 11.Pregnancy 12.Lactation

Design outcomes

Primary

Measure	Time frame
Primary outcome will be assessed by measuring Peak expiratory flow pre and post treatment using peak flow meterTimepoint: 2 MONTHS - SCREENING 2 MONTHS - PATIENT ENROLLMENT 2 MONTHS - OUTCOME ASSESSMENT	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing clinical signs and symptoms, laboratory parameters of IgE, AEC, ESR before and after treatment.Timepoint: 2 MONTHS - SCREENING 2 MONTHS - PATIENT ENROLLMENT 2 MONTHS - OUTCOME ASSESSMENT	—

Countries

India

Contacts

Public ContactDr C Selvalenin

National Institute of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026